Andervont et al., 1939 - Google Patents
The effect of ascorbic acid upon the hemorrhage produced by bacterial filtrate in transplanted tumorsAndervont et al., 1939
- Document ID
- 8112342709998695838
- Author
- Andervont H
- Shimkin M
- Publication year
- Publication venue
- The American Journal of Cancer
External Links
Snippet
Interest in the effect of bacterial preparations on malignant tumors, noted over fifty years ago (1), was revived in 1931 by Gratia and Linz (2), who demonstrated hemorrhage in transplanted liposarcoma of guinea-pigs after injection of filtrate of B. coli. Various phases of …
- 239000000706 filtrate 0 title abstract description 80
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ozols et al. | Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione | |
| Lijinsky et al. | Liver tumors induced in rats by oral administration of the antihistaminic methapyrilene hydrochloride | |
| McDONALD et al. | The prophylactic treatment of malignant disease with nitrogen mustard and triethylenethiophosphoramide (Thio TEPA) | |
| Broom et al. | The pharmacology of patulin | |
| AU759278B2 (en) | Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate | |
| US3224942A (en) | Anti-inflammatory, anti-edema and anti-thrombi drug | |
| Douglas et al. | The respiratory stimulant action of 5-hydroxytryptamine (serotonin) in the dog | |
| Taylor et al. | Studies with crystalline trypsin: results and hazards of intravenous administration and its postulated role in blood coagulation | |
| Andervont et al. | The effect of ascorbic acid upon the hemorrhage produced by bacterial filtrate in transplanted tumors | |
| Leopold | Ocular cholinesterase and cholinesterase inhibitors: The Friedenwald Memorial lecture | |
| Arem et al. | Effects of low-dose BAPN on wound healing | |
| Collier et al. | Rapid induction by acetylcholine, bradykinin and potassium of a nociceptive response in mice and its selective antagonism by aspirin | |
| Daly | The first international urokinase/warfarin trial in colorectal cancer | |
| Roschlau et al. | Thrombolytic therapy with local perfusions of CA-7 (fibrinolytic enzyme from Aspergillus oryzae) in the dog | |
| Rong et al. | Inhibition of tumor angiogenesis by hexuronyl hexosaminoglycan sulfate | |
| Maniglia et al. | The effect of 2, 6-bis (diethanolamino)-4-piperidinopyrimido [5, 4-d]-pyrimidine (RA233) on growth, metastases and lung colony formation of B16 melanoma | |
| Alimena et al. | Interferon alpha‐2b as therapy for patients with Ph ‘‐positive chronic myelogenous leukemia | |
| DE10212555A1 (en) | Detecting and suppressing growth of malignant tumors and their metastases, comprises administration of coagulation factor Xa inhibitors | |
| Clark et al. | Effect of flavonoid (vitamin P-like) substances on histamine toxicity, anaphylactic shock, histamine-enhanced capillary permeability to dye, and bleeding time; with data on the toxicity of flavonoids | |
| Müller-Berghaus et al. | Experimental galactosamine-induced hepatitis. Effect of anticoagulant and antifibrinolytic agents on microclot formation | |
| US4767763A (en) | Composition for achieving tumor reversion and its use in cancerology for dogs | |
| Davis et al. | The combination of sympathectomy and thiocyanates in the treatment of experimental and essential, or high diastolic, hypertension | |
| JPH03503644A (en) | Heparin-containing preparations | |
| Girolami et al. | Acute superficial phlebitis in a patient with hemophilia A: probably a iatrogenic effect | |
| Simpson et al. | Partial antagonism of experimental botulinal intoxication |